Atypical Antipsychotic Drugs: Part 1
Norman L. Keltner, Heather Coffeen, Janna E. Johnson
Abstract
Open-access reader
Norman L. Keltner, Heather Coffeen, Janna E. Johnson
Abstract
Open-access reader
This column on atypical antipsychotics is the first of two parts. Part I consists of a review of foundational information and a discussion on clozapine and risperidone. Part II will address olanzapine, quetiapine, and ziprasidone.
OpenAlex reports 3 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
This column on atypical antipsychotics is the first of two parts. Part I consists of a review of foundational information and a discussion on clozapine and risperidone. Part II will address olanzapine, quetiapine, and ziprasidone.
Key concepts: Ziprasidone, Quetiapine, Olanzapine, Risperidone, Clozapine, Atypical antipsychotic, Medicine, Psychiatry